4//SEC Filing
Kraws Jeffrey J 4
Accession 0001104659-22-127975
CIK 0000894158other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 6:17 PM ET
Size
5.6 KB
Accession
0001104659-22-127975
Insider Transaction Report
Form 4
Kraws Jeffrey J
Director
Transactions
- Award
Stock Options (right to buy)
2022-12-15+100,000→ 100,000 totalExercise: $0.58From: 2023-01-15Exp: 2029-12-15→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]These stock options vest pro rata on a monthly basis over 12 months.
Documents
Issuer
Theriva Biologics, Inc.
CIK 0000894158
Entity typeother
Related Parties
1- filerCIK 0001380918
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 6:17 PM ET
- Size
- 5.6 KB